Total Payments
$5,886
2024 Payments
$302.92
Companies
13
Transactions
131
Medicare Patients
8,332
Medicare Billing
$7.2M
Payment Breakdown by Category
Gifts$3,741 (63.6%)
Food & Beverage$2,145 (36.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Gift | $3,741 | 3 | 63.6% |
| Food and Beverage | $2,145 | 128 | 36.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Carl Zeiss Meditec, Inc. | $3,741 | 3 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $688.66 | 46 | $0 (2024) |
| Alimera Sciences, Inc. | $354.80 | 25 | $0 (2024) |
| Genentech USA, Inc. | $248.64 | 16 | $0 (2024) |
| EyePoint Pharmaceuticals US, Inc. | $212.07 | 7 | $0 (2023) |
| Allergan, Inc. | $165.09 | 10 | $0 (2021) |
| Halozyme Inc | $134.00 | 1 | $0 (2021) |
| ABBVIE INC. | $98.60 | 7 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $68.60 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $60.04 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $302.92 | 17 | Regeneron Healthcare Solutions, Inc. ($177.46) |
| 2023 | $407.49 | 23 | Regeneron Healthcare Solutions, Inc. ($173.58) |
| 2022 | $425.38 | 25 | Regeneron Healthcare Solutions, Inc. ($137.00) |
| 2021 | $384.48 | 19 | Halozyme Inc ($134.00) |
| 2020 | $111.22 | 9 | Allergan, Inc. ($62.76) |
| 2019 | $2,564 | 17 | Carl Zeiss Meditec, Inc. ($2,359) |
| 2018 | $1,512 | 11 | Carl Zeiss Meditec, Inc. ($1,382) |
| 2017 | $178.99 | 10 | Regeneron Healthcare Solutions, Inc. ($57.22) |
All Payment Transactions
131 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/11/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/04/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/06/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/26/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/24/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: EYE CARE | ||||||
| 07/08/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/03/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/17/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/08/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/07/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Ophthalmology | ||||||
| 05/01/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/16/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 04/03/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/27/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/17/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: EYE CARE | ||||||
| 02/08/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/06/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/03/2023 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $13.87 | General |
| 11/01/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/25/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $14.60 | General |
| Category: Ophthalmology | ||||||
| 10/23/2023 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Ophthalmology | ||||||
| 10/17/2023 | Alimera Sciences, Inc. | YUTIQ (Drug) | Food and Beverage | Cash or cash equivalent | $14.96 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/13/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/30/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/16/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 2,021 | 29,778 | $3.2M | $1.6M |
| 2022 | 15 | 2,029 | 8,100 | $3.3M | $1.6M |
| 2021 | 13 | 2,157 | 6,649 | $4.0M | $2.0M |
| 2020 | 14 | 2,125 | 6,800 | $4.0M | $2.0M |
Total Patients
8,332
Total Services
51,327
Medicare Billing
$7.2M
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 80 | 25,320 | $1.3M | $735,727 | 58.1% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 117 | 882 | $1.1M | $610,480 | 53.2% |
| 67028 | Injection of drug into eye | Office | 2023 | 176 | 799 | $389,200 | $81,023 | 20.8% |
| 92134 | Imaging of retina | Office | 2023 | 609 | 1,390 | $138,880 | $44,619 | 32.1% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 412 | 454 | $90,800 | $42,321 | 46.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 299 | 581 | $78,435 | $41,353 | 52.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 93 | 93 | $27,900 | $12,444 | 44.6% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 81 | 88 | $4,400 | $1,788 | 40.6% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 23 | 30 | $2,700 | $1,690 | 62.6% |
| 92250 | Photography of the retina | Office | 2023 | 51 | 51 | $6,375 | $1,662 | 26.1% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 18 | 28 | $8,400 | $1,023 | 12.2% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 62 | 62 | $2,790 | $736.62 | 26.4% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 177 | 1,620 | $2.1M | $1.2M | 55.2% |
| 67028 | Injection of drug into eye | Office | 2022 | 200 | 848 | $412,000 | $86,876 | 21.1% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 24 | 2,640 | $132,000 | $78,781 | 59.7% |
| J3590 | Unclassified biologics | Office | 2022 | 17 | 42 | $137,970 | $74,492 | 54.0% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 12 | 225 | $123,750 | $49,695 | 40.2% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 425 | 499 | $99,800 | $47,548 | 47.6% |
| 92134 | Imaging of retina | Office | 2022 | 603 | 1,361 | $135,880 | $44,877 | 33.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 300 | 553 | $74,655 | $38,762 | 51.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 65 | 65 | $19,500 | $8,585 | 44.0% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2022 | 15 | 23 | $34,500 | $6,762 | 19.6% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2022 | 80 | 95 | $4,750 | $1,916 | 40.3% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 20 | 32 | $3,040 | $1,744 | 57.4% |
| 92250 | Photography of the retina | Office | 2022 | 41 | 43 | $5,375 | $1,428 | 26.6% |
About Dr. Brett Foxman, MD
Dr. Brett Foxman, MD is a Ophthalmology healthcare provider based in Northfield, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376518738.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brett Foxman, MD has received a total of $5,886 in payments from pharmaceutical and medical device companies, with $302.92 received in 2024. These payments were reported across 131 transactions from 13 companies. The most common payment nature is "Gift" ($3,741).
As a Medicare-enrolled provider, Foxman has provided services to 8,332 Medicare beneficiaries, totaling 51,327 services with total Medicare billing of $7.2M. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist, Ophthalmology
- Location Northfield, NJ
- Active Since 02/21/2006
- Last Updated 09/11/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1376518738
Products in Payments
- VISUCAM Fundus Cameras (Device) $3,741
- EYLEA (Biological) $469.74
- YUTIQ (Drug) $249.20
- OZURDEX (Drug) $201.82
- ILUVIEN (Drug) $162.14
- EYLEA HD (Biological) $137.02
- HYLENEX RECOMBINANT (Drug) $134.00
- Lucentis (Biological) $117.41
- Iluvien (Drug) $103.09
- Vabysmo (Drug) $87.06
- EYLEA AFLIBERCEPT INJECTION (Biological) $81.90
- Syfovre (Drug) $68.60
- XIPERE (Drug) $56.69
- BEOVU (Drug) $48.61
- VABYSMO (Drug) $44.17
- ACTHAR (Biological) $26.57
- Humira (Biological) $13.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.